Dexamethasone Sodium Phosphate (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Dexamethasone Sodium Phosphate drug offered from Fresenius Kabi USA, LLC. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | Dexamethasone Sodium Phosphate |
SUBSTANCE NAME: | DEXAMETHASONE SODIUM PHOSPHATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-10-30 |
END MARKETING DATE: | 0000-00-00 |
Dexamethasone Sodium Phosphate HUMAN PRESCRIPTION DRUG Details:
Item Description | Dexamethasone Sodium Phosphate from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/mL) |
START MARKETING DATE: | 2015-10-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76045-106_56426d41-81ca-4b49-9a9d-07b74ec706a1 |
PRODUCT NDC: | 76045-106 |
APPLICATION NUMBER: | ANDA203129 |
Other DEXAMETHASONE SODIUM PHOSPHATE Pharmaceutical Manufacturers / Labelers: